Last update 02 Apr 2026

Autologous tumour-reactive lymphocytes(SentoClone AB)

Overview

Basic Info

Drug Type
Immune cell therapy
Synonyms
SentoClone
Target-
Action-
Mechanism
Cell replacements
Therapeutic Areas
NeoplasmsSkin and Musculoskeletal DiseasesDigestive System Disorders+ [1]
Active Indication-
Inactive Indication
Bladder CancerColorectal CancerMelanoma
Originator Organization
SentoClone AB
Active Organization-
Inactive Organization
SentoClone AB
License Organization-
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Autologous tumour-reactive lymphocytes(SentoClone AB)
NCT00991250
/ Unknown statusPhase 2
A Multi-centre, Two-arm, Randomized, Open, Phase II Study Investigating SentoClone® Compared to Reference Treatment in Advanced Malignant Melanoma
100 Clinical Results associated with Autologous tumour-reactive lymphocytes(SentoClone AB)
Login to view more data
100 Translational Medicine associated with Autologous tumour-reactive lymphocytes(SentoClone AB)
Login to view more data
100 Patents (Medical) associated with Autologous tumour-reactive lymphocytes(SentoClone AB)
Login to view more data
100 Deals associated with Autologous tumour-reactive lymphocytes(SentoClone AB)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
MelanomaPhase 2
Sweden
SentoClone AB
01 Oct 2009
Bladder CancerPhase 1
Sweden
SentoClone AB
05 Jun 2013
Colorectal CancerPhase 1
Sweden
SentoClone AB
05 Jun 2013
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free